75 related articles for article (PubMed ID: 9464323)
1. [Selection of clinical evaluation criterion and method of measurement].
Inamura K; Inoue T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):7-12. PubMed ID: 9464323
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
3. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
Konski A; Sherman E; Krahn M; Bremner K; Beck JR; Watkins-Bruner D; Pilepich M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):788-94. PubMed ID: 16109464
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness studies in radiation therapy.
Sher DJ
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
[TBL] [Abstract][Full Text] [Related]
6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
7. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer.
Konski A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1373-8. PubMed ID: 15590167
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
12. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
13. CHART in lung cancer: economic evaluation and incentives for implementation.
Lievens Y; Kesteloot K; Van den Bogaert W
Radiother Oncol; 2005 May; 75(2):171-8. PubMed ID: 15878631
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
16. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
17. Considerations of cost-effectiveness for new radiation oncology technologies.
Mills MD; Spanos WJ; Esterhay RJ
J Am Coll Radiol; 2006 Apr; 3(4):278-88. PubMed ID: 17412060
[TBL] [Abstract][Full Text] [Related]
18. [The cost of radiotherapy. Evaluation of the real cost of treatments performed in a radiotherapy service of a center for fight against cancer].
Daly-Schveitzer N; Delmas S; Bonhomme C; Verdier A
Bull Cancer Radiother; 1995; 82(4):370-8. PubMed ID: 8554890
[TBL] [Abstract][Full Text] [Related]
19. Preferences for health outcomes and cost-utility analysis.
Torrance GW
Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
[TBL] [Abstract][Full Text] [Related]
20. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
